Skip to main content
Clinical Trials/NCT03559621
NCT03559621CompletedNot Applicable

Mobile-based Lifestyle Intervention in Women With Glucose Intolerance After Gestational Diabetes

Universitaire Ziekenhuizen KU Leuven7 sites in 1 country240 target enrollmentStarted: April 14, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
240
Locations
7
Primary Endpoint
weight-loss goal

Study Overview

Brief Summary

Although lifestyle modification programs have been shown to be effective in preventing diabetes in older populations, interventions in women with recent gestational diabetes (GDM) clearly need to be adapted to address their unique barriers to behavior change in order to optimize adherence. The low participating rates in many studies using individual or group sessions, reflect how difficult it is to engage women in the first years postpartum. Since women with glucose intolerance (prediabetes) have the highest risk to develop type 2 diabetes (T2DM), we designed the MELINDA pilot study, a randomized controlled trial with 1 year of follow-up to evaluate the efficacy and feasibility of a telephone -and mobile (app) based lifestyle coaching intervention in women with glucose intolerance after a recent history of GDM to promote a healthy lifestyle.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •aged 18 or older
  • •GDM based on the 2013 WHO criteria
  • •glucose intolerance (prediabetes based on the ADA criteria) based on the 75g OGTT 6-16 weeks after delivery

Exclusion Criteria

  • •diabetes;
  • •current use of metformin;
  • •normal glucose tolerance (ADA criteria);
  • •health limitations or treatments which would restrict the participation in the intervention trial.
  • •Has no smartphone

Arms & Interventions

control group

No Intervention

Women in the control group will receive follow-up as in normal routine with referral to primary care. They will receive an OGTT after 1 year as part of the trial.

intervention group

Other

A mobile-based lifestyle intervention

Intervention: mobile-based lifestyle intervention (Behavioral)

Outcomes

Primary Outcomes

weight-loss goal

Time Frame: 1 year

reaching the weight-loss goal ≥5% of body weight when overweight or obese or returning to pre-gravid weight if normal BMI

Secondary Outcomes

  • prediabetes(1 year postpartum)
  • insulin resistance HOMA-IR(1 year)
  • dietary quality(1 year)
  • diabetes(1 year)
  • metabolic syndrome(6-16 weeks postpartum)
  • duration breastfeeding(1 year)
  • rate exclusive breastfeeding(1 year)
  • depression(1 year)
  • Sence of Coherence(1 year)
  • beta-cell function ISSI-2 index(1 year)
  • beta-cell function insulinogenic index(1 year)
  • insulin resistance Matsuda(1 year)
  • beta-cell function HOMA-B(1 year)
  • weight loss(1 year)
  • quality of life(1 year)
  • anxiety(1 year)
  • motivation for behavior change(1 year)
  • physical activity IPAQ(1 year)
  • diabetes risk perception(1 year)
  • physical activity pedometer(1 year)
  • prediabetes(6-16 weeks postpartum)
  • metabolic syndrome(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials